These encompass decreased bone mineral density (BMD), compromised bone microstructure, and an increased risk of fractures
The contribution of glucagon receptor activation to intestinal fluid secretion has been proposed but is not yet established, and should be regarded as speculative at this stage
You can request dose adjustments, report side effects, or ask questions about nutrition and exercise
Tirzepatide works differently because it activates both GLP-1 and GIP receptors
Here are some of the signs research has connected to low selenium in women: Irregular or delayed menstrual cycles Reduced fertility or difficulty conceiving Higher risk of gestational issues , including preeclampsia Poor thyroid function , affecting metabolism and hormone output Mood swings or fatigue that may have hormonal roots These symptoms often overlap with other hormonal or metabolic imbalances, which is why proper nutrient intake, including selenium, can be such a helpful piece of the puzzle
Retatrutide (a triple GIP/GLP-1/glucagon receptor agonist), survodutide, mazdutide, and CagriSema represent the next generation of anti-obesity compounds that may offer even greater efficacy or better tolerability profiles